The average person with Atrial Fibrilation (AFib) is 5 times more likely to suffer a stroke than someone with a regular heartbeat1
Leave blood thinners behind
AFib doesn't have to mean a lifetime of risk and constant worry about the side effects of blood thinners. For people who need to consider another option due to bleeding or stroke events, WATCHMAN Implant can be an option. The WATCHMAN Implant is a safe, minimally invasive, one-time implant for people with non-valvular atrial fibrillation (AFib) that lowers your stroke risk – without the need for lifelong blood thinners. In a clinical trial, 96% of people were able to stop taking their blood thinners 45 days after getting the WATCHMAN Implant.1
There are risks associated with all medical procedures. Please talk with your doctor about the risks and benefits of the WATCHMAN Implant.
Atrial Fibrilation is a growing problem.
The WATCHMAN Implant reduces the risk of stroke from non‑valvular AFib
Blood thinners aren't the only option to reduce AFib stroke risk. The WATCHMAN Implant is the most implanted FDA-approved device proven to reduce stroke risk in people with atrial fibrillation not caused by a heart valve problem.
Watch the video to learn more and talk to your doctor about the WATCHMAN Implant.
Over 600.000 people have left blood thinners behind with the WATCHMAN Implant
Real people who chose the WATCHMAN Implant
Meet people living free from worrying about stroke risk and serious bleeding events – thanks to the WATCHMAN Implant.
DANIEL TALKS WITH DR. FLOOD
“WATCHMAN is about restoring lives.”
When Dr. Flood realised Daniel was less active and less happy on blood thinners, he recommended the WATCHMAN Implant.
Keep exploring
AFib and stroke risk
Understanding atrial fibrillation and its connection to stroke risk helps you take control, so you can worry less and enjoy life more.
How the WATCHMAN Implant works
The WATCHMAN Implant reduces stroke risk and bleeding worry with a one-time, minimally invasive procedure.
Resources
Interested in more information? Download the brochure, watch videos, connect with others and more.
“We are people living with AFib.”
An introduction to the population of 600.000+ people who've left blood thinners behind and said goodbye to their bleeding worry – for life.
*In a clinical trial, 96% of patients were able to discontinue their blood thinner 45 days after getting the WATCHMAN Implant.
References:
1. Kar, S., et al, Primary Outcome Evaluation of the Next Generation LAAC Device: Results from the PINNACLE FLX Trial, Circulation, 2021.
CAUTION:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.